BindingDB logo
myBDB logout

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
9554869 15 Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria.EBI University of Manchester
16750361 11 Analysis of complexes of inhibitors with Cryptosporidium hominis DHFR leads to a new trimethoprim derivative.EBI Dartmouth College
15293997 52 Three-dimensional quantitative structure-activity relationship analysis of a set of Plasmodium falciparum dihydrofolate reductase inhibitors using a pharmacophore generation approach.EBI Università
14736247 361 Inhibitors of multiple mutants of Plasmodium falciparum dihydrofolate reductase and their antimalarial activities.EBI National Center For Genetic Engineering and Biotechnology At Thailand
14711307 289 Target guided synthesis of 5-benzyl-2,4-diamonopyrimidines: their antimalarial activities and binding affinities to wild type and mutant dihydrofolate reductases from Plasmodium falciparum.EBI National Center For Genetic Engineering and Biotechnology At Thailand
12825927 84 Docking and database screening reveal new classes of Plasmodium falciparum dihydrofolate reductase inhibitors.EBI Università
11881993 175 Development of 2,4-diaminopyrimidines as antimalarials based on inhibition of the S108N and C59R+S108N mutants of dihydrofolate reductase from pyrimethamine-resistant Plasmodium falciparum.EBI National Center For Genetic Engineering and Biotechnology At Thailand
29111368 43 Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely.EBI East China University of Science and Technology
1495020 14 Probing the molecular basis of resistance to pyrimethamine by site-directed mutagenesis.EBI Pennsylvania State University